These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23501351)

  • 1. [Impact of cancer treatments on cognitive functions: the patients' view, their expectation and their interest in participating to cognitive rehabilitation workshops].
    Le Fel J; Daireaux A; Vandenbosshe S; Heutte N; Rigal O; Rovira K; Joly F; Roy V
    Bull Cancer; 2013 Mar; 100(3):223-9. PubMed ID: 23501351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of specific neuropsychological training programs for breast cancer patients after adjuvant chemotherapy.
    Poppelreuter M; Weis J; Bartsch HH
    J Psychosoc Oncol; 2009; 27(2):274-96. PubMed ID: 19337933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy-induced prospective memory impairment in patients with breast cancer.
    Cheng H; Yang Z; Dong B; Chen C; Zhang M; Huang Z; Chen Z; Wang K
    Psychooncology; 2013 Oct; 22(10):2391-5. PubMed ID: 23674402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive problems after chemotherapy for breast cancer.
    Harv Womens Health Watch; 2002 Oct; 10(2):5-6. PubMed ID: 12393318
    [No Abstract]   [Full Text] [Related]  

  • 5. Information about chemotherapy-associated cognitive problems contributes to cognitive problems in cancer patients.
    Schagen SB; Das E; Vermeulen I
    Psychooncology; 2012 Oct; 21(10):1132-5. PubMed ID: 21769988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of priming and pre-existing knowledge of chemotherapy-associated cognitive complaints on the reporting of such complaints in breast cancer patients.
    Schagen SB; Das E; van Dam FS
    Psychooncology; 2009 Jun; 18(6):674-8. PubMed ID: 19021129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-related cognitive impairment: the breast cancer experience.
    Myers JS
    Oncol Nurs Forum; 2012 Jan; 39(1):E31-40. PubMed ID: 22201666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment.
    Downie FP; Mar Fan HG; Houédé-Tchen N; Yi Q; Tannock IF
    Psychooncology; 2006 Oct; 15(10):921-30. PubMed ID: 16477674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-analysis of the effects of chemotherapy on cognition in patients with cancer.
    Hodgson KD; Hutchinson AD; Wilson CJ; Nettelbeck T
    Cancer Treat Rev; 2013 May; 39(3):297-304. PubMed ID: 23219452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
    Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
    Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive side-effects of adjuvant treatments.
    Burstein HJ
    Breast; 2007 Dec; 16 Suppl 2():S166-8. PubMed ID: 17719225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive dysfunctions in elderly cancer patients: a new challenge for oncologists.
    Lange M; Rigal O; Clarisse B; Giffard B; Sevin E; Barillet M; Eustache F; Joly F
    Cancer Treat Rev; 2014 Jul; 40(6):810-7. PubMed ID: 24713425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study.
    Biglia N; Bounous VE; Malabaila A; Palmisano D; Torta DM; D'Alonzo M; Sismondi P; Torta R
    Eur J Cancer Care (Engl); 2012 Jul; 21(4):485-92. PubMed ID: 22211832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study.
    Quesnel C; Savard J; Ivers H
    Breast Cancer Res Treat; 2009 Jul; 116(1):113-23. PubMed ID: 18629633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive adverse effects of chemotherapy in breast cancer patients.
    Correa DD; Ahles TA
    Curr Opin Support Palliat Care; 2007 Apr; 1(1):57-62. PubMed ID: 18660726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive functions and elderly cancer patients receiving anticancer treatment: a prospective study.
    Minisini AM; De Faccio S; Ermacora P; Andreetta C; Fantinel R; Balestrieri M; Piga A; Puglisi F
    Crit Rev Oncol Hematol; 2008 Jul; 67(1):71-9. PubMed ID: 18394917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Chemobrain': concentration and memory effects in people receiving chemotherapy - a descriptive phenomenological study.
    Mitchell T; Turton P
    Eur J Cancer Care (Engl); 2011 Jul; 20(4):539-48. PubMed ID: 21443746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study.
    Jenkins V; Shilling V; Fallowfield L; Howell A; Hutton S
    Psychooncology; 2004 Jan; 13(1):61-6. PubMed ID: 14745746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemobrain is real but may need new name.
    Hede K
    J Natl Cancer Inst; 2008 Feb; 100(3):162-3, 169. PubMed ID: 18230787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.